According to Hillstream BioPharma's latest financial reports the company has a price-to-book ratio of 2.37.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.37 | 192.89% |
2022-12-31 | 0.8107 | |
2021-12-31 | N/A | |
2020-12-31 | N/A |